HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Nishimura Selected Research

G Nishimura Research Topics

Disease

9Neoplasms (Cancer)
01/2013 - 03/2000
7Neoplasm Metastasis (Metastasis)
07/2002 - 02/2000
5Carcinoma (Carcinomatosis)
10/2001 - 03/2000
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2013 - 07/2000
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2001 - 12/2000
2Strudwick syndrome
12/2011 - 02/2001
2Stomach Neoplasms (Stomach Cancer)
07/2002 - 02/2000
2Head and Neck Neoplasms (Head and Neck Cancer)
10/2001 - 07/2000
2Squamous Cell Carcinoma of Head and Neck
10/2000 - 05/2000
1Type V Osteogenesis Imperfecta
12/2021
1Osteoporosis
12/2021
1Colonic Neoplasms (Colon Cancer)
11/2015
1Metatropic dwarfism
10/2010
1Brachyolmia
10/2010
1Kozlowski type Spondylometaphyseal dysplasia
10/2010
1Congenital Abnormalities (Deformity)
01/2010
1Scoliosis
01/2010
1Colorectal Neoplasms (Colorectal Cancer)
10/2001
1Rectal Neoplasms (Rectal Cancer)
10/2001
1Myeloid Leukemia (Leukemia, Myelocytic)
09/2001
1Alcoholic Fatty Liver
03/2001
1Fatty Liver
03/2001
1Pyle disease
02/2001
1Madelung Deformity
01/2001
1Alopecia (Baldness)
10/2000
1Cataract (Cataracts)
10/2000
1Chondrodysplasia Punctata (Stippled Epiphyses)
10/2000
1Ichthyosis (Xeroderma)
10/2000
1Islet Cell Carcinoma
10/2000
1Stomach Ulcer (Gastric Ulcer)
10/2000
1Herpes Simplex
05/2000
1Carcinogenesis
03/2000
1Esophageal Squamous Cell Carcinoma
03/2000

Drug/Important Bio-Agent (IBA)

2TegafurIBA
11/2015 - 10/2001
2UracilIBA
11/2015 - 10/2000
2O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
10/2001 - 07/2000
2Angiogenesis InhibitorsIBA
10/2001 - 07/2000
2Fluorouracil (Carac)FDA LinkGeneric
10/2000 - 10/2000
2Therapeutic UsesIBA
10/2000 - 05/2000
1SphingomyelinsIBA
12/2021
1ceramide cholinephosphotransferaseIBA
12/2021
15' Untranslated Regions (5' UTR)IBA
12/2021
1Proteins (Proteins, Gene)FDA Link
12/2021
1Leucovorin (Folinic Acid)FDA Link
11/2015
1Collagen Type II (Type II Collagen)IBA
12/2011
1CationsIBA
10/2010
1Interleukin-8 (Interleukin 8)IBA
10/2001
1PotassiumIBA
10/2001
1titanium silicide (TS-1)IBA
10/2001
1fumagillolIBA
10/2001
1fumagillinIBA
10/2001
1Cytochromes c (Cytochrome c)IBA
09/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2001
1S100 Calcium-Binding Protein A4IBA
04/2001
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2001
1EndotoxinsIBA
03/2001
1Collagen Type XIBA
02/2001
1Fas Ligand Protein (Fas Ligand)IBA
01/2001
1fas Receptor (CD95 Antigen)IBA
01/2001
1Differentiation AntigensIBA
12/2000
12,4-thiazolidinedione (thiazolidinedione)IBA
12/2000
1LigandsIBA
12/2000
1PPAR gammaIBA
12/2000
1Probucol (Lorelco)FDA Link
11/2000
1tiracoxibIBA
11/2000
1potassium oxonateIBA
10/2000
1Cytidine Diphosphate (CDP)IBA
10/2000
1Cisplatin (Platino)FDA LinkGeneric
07/2000
1AntibodiesIBA
05/2000
1Interferon-gamma (Interferon, gamma)IBA
05/2000
1asialo GM1 gangliosideIBA
05/2000
1Cancer VaccinesIBA
05/2000
1Interleukin-2 (IL2)IBA
05/2000
1Cadherins (E-Cadherin)IBA
03/2000
1beta CateninIBA
03/2000
1CateninsIBA
03/2000
1alpha Catenin (alpha E-Catenin)IBA
03/2000

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2013 - 02/2000
4Therapeutics
10/2001 - 02/2000
2Radiotherapy
01/2013 - 01/2010
2Combination Drug Therapy (Combination Chemotherapy)
10/2001 - 02/2000
2Hepatectomy
10/2000 - 10/2000
1Adjuvant Chemotherapy
11/2015
1Duration of Therapy
11/2015
1Laryngectomy
01/2013
1Nephrectomy
01/2010
1Laparotomy
07/2002
1Oral Administration
10/2001
1Immunotherapy
05/2000
1Neoadjuvant Therapy
02/2000